An enrichment of SMAD6 variantsconsidered to be pathogenic has been reported in several pathologies distinctfrom CRS.10–17 Using our variant categorization (based onAF and DS), we evaluated all SMAD6 variantsthat were previously reported as pathogenic. This evidence concerns the gene SMAD6 and congenital rubella syndrome.